nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Fluorouracil—pancreatic cancer	0.0451	0.0645	CbGbCtD
Nifedipine—CYP1A1—Dacarbazine—pancreatic cancer	0.0292	0.0417	CbGbCtD
Nifedipine—ABCC2—Tamoxifen—pancreatic cancer	0.0278	0.0398	CbGbCtD
Nifedipine—CYP2A6—Tamoxifen—pancreatic cancer	0.0272	0.0389	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—pancreatic cancer	0.0257	0.0367	CbGbCtD
Nifedipine—CYP1A1—Tamoxifen—pancreatic cancer	0.0232	0.0332	CbGbCtD
Nifedipine—CYP2E1—Dacarbazine—pancreatic cancer	0.0225	0.0322	CbGbCtD
Nifedipine—ABCC2—Irinotecan—pancreatic cancer	0.0213	0.0306	CbGbCtD
Nifedipine—CYP2A6—Fluorouracil—pancreatic cancer	0.02	0.0286	CbGbCtD
Nifedipine—CYP1A1—Erlotinib—pancreatic cancer	0.0197	0.0282	CbGbCtD
Nifedipine—CYP3A7—Tamoxifen—pancreatic cancer	0.0186	0.0266	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0186	0.0266	CbGbCtD
Nifedipine—CYP2E1—Tamoxifen—pancreatic cancer	0.0179	0.0257	CbGbCtD
Nifedipine—CYP2B6—Tamoxifen—pancreatic cancer	0.0177	0.0253	CbGbCtD
Nifedipine—ABCC2—Docetaxel—pancreatic cancer	0.0156	0.0224	CbGbCtD
Nifedipine—ABCC2—Sunitinib—pancreatic cancer	0.0156	0.0223	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0143	0.0204	CbGbCtD
Nifedipine—CYP3A7—Irinotecan—pancreatic cancer	0.0143	0.0204	CbGbCtD
Nifedipine—CYP3A5—Tamoxifen—pancreatic cancer	0.0139	0.0199	CbGbCtD
Nifedipine—CYP2B6—Irinotecan—pancreatic cancer	0.0136	0.0194	CbGbCtD
Nifedipine—CYP2C8—Tamoxifen—pancreatic cancer	0.0134	0.0192	CbGbCtD
Nifedipine—CYP1A2—Dacarbazine—pancreatic cancer	0.013	0.0186	CbGbCtD
Nifedipine—CYP3A5—Erlotinib—pancreatic cancer	0.0118	0.0169	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—pancreatic cancer	0.0117	0.0167	CbGbCtD
Nifedipine—CYP2C8—Erlotinib—pancreatic cancer	0.0114	0.0163	CbGbCtD
Nifedipine—CYP3A5—Irinotecan—pancreatic cancer	0.0107	0.0153	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0104	0.015	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—pancreatic cancer	0.0104	0.015	CbGbCtD
Nifedipine—CYP3A7—Sunitinib—pancreatic cancer	0.0104	0.0149	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0104	0.0149	CbGbCtD
Nifedipine—CYP1A2—Tamoxifen—pancreatic cancer	0.0104	0.0148	CbGbCtD
Nifedipine—CYP2C8—Fluorouracil—pancreatic cancer	0.00987	0.0141	CbGbCtD
Nifedipine—CYP2C9—Tamoxifen—pancreatic cancer	0.00934	0.0134	CbGbCtD
Nifedipine—ABCB1—Tamoxifen—pancreatic cancer	0.00906	0.013	CbGbCtD
Nifedipine—CYP1A2—Erlotinib—pancreatic cancer	0.00881	0.0126	CbGbCtD
Nifedipine—CYP2D6—Tamoxifen—pancreatic cancer	0.00854	0.0122	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—pancreatic cancer	0.00784	0.0112	CbGbCtD
Nifedipine—ABCB1—Gemcitabine—pancreatic cancer	0.00781	0.0112	CbGbCtD
Nifedipine—CYP3A5—Sunitinib—pancreatic cancer	0.0078	0.0112	CbGbCtD
Nifedipine—ABCC3—bile duct—pancreatic cancer	0.00773	0.206	CbGeAlD
Nifedipine—ABCB1—Erlotinib—pancreatic cancer	0.0077	0.011	CbGbCtD
Nifedipine—CYP1A2—Fluorouracil—pancreatic cancer	0.00764	0.0109	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—pancreatic cancer	0.00741	0.0106	CbGbCtD
Nifedipine—CYP2D6—Erlotinib—pancreatic cancer	0.00726	0.0104	CbGbCtD
Nifedipine—ABCB1—Irinotecan—pancreatic cancer	0.00696	0.00996	CbGbCtD
Nifedipine—CYP2C9—Fluorouracil—pancreatic cancer	0.00688	0.00985	CbGbCtD
Nifedipine—ABCC2—bile duct—pancreatic cancer	0.00618	0.165	CbGeAlD
Nifedipine—CYP3A4—Tamoxifen—pancreatic cancer	0.00543	0.00777	CbGbCtD
Nifedipine—ABCB1—Docetaxel—pancreatic cancer	0.0051	0.0073	CbGbCtD
Nifedipine—ABCB1—Sunitinib—pancreatic cancer	0.00508	0.00727	CbGbCtD
Nifedipine—ABCC2—bile—pancreatic cancer	0.00475	0.126	CbGeAlD
Nifedipine—CYP3A4—Erlotinib—pancreatic cancer	0.00462	0.00661	CbGbCtD
Nifedipine—CYP3A4—Irinotecan—pancreatic cancer	0.00417	0.00597	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—pancreatic cancer	0.0038	0.00544	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—pancreatic cancer	0.00358	0.00513	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—pancreatic cancer	0.00306	0.00437	CbGbCtD
Nifedipine—CYP3A4—Sunitinib—pancreatic cancer	0.00304	0.00435	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—pancreatic cancer	0.00228	0.00326	CbGbCtD
Nifedipine—ABCC3—gall bladder—pancreatic cancer	0.00165	0.0439	CbGeAlD
Nifedipine—CACNB2—islet of Langerhans—pancreatic cancer	0.00147	0.0392	CbGeAlD
Nifedipine—CACNA1D—islet of Langerhans—pancreatic cancer	0.00129	0.0343	CbGeAlD
Nifedipine—Nimodipine—AHR—pancreatic cancer	0.00127	1	CrCbGaD
Nifedipine—CALM2—gall bladder—pancreatic cancer	0.00119	0.0318	CbGeAlD
Nifedipine—CALM3—islet of Langerhans—pancreatic cancer	0.000995	0.0265	CbGeAlD
Nifedipine—CACNA1D—pancreas—pancreatic cancer	0.000905	0.0241	CbGeAlD
Nifedipine—CACNB2—digestive system—pancreatic cancer	0.000884	0.0236	CbGeAlD
Nifedipine—CALM2—islet of Langerhans—pancreatic cancer	0.000781	0.0208	CbGeAlD
Nifedipine—CALM1—islet of Langerhans—pancreatic cancer	0.000778	0.0207	CbGeAlD
Nifedipine—CACNA1C—digestive system—pancreatic cancer	0.000713	0.019	CbGeAlD
Nifedipine—CALM3—pancreas—pancreatic cancer	0.000699	0.0186	CbGeAlD
Nifedipine—ABCC3—digestive system—pancreatic cancer	0.000649	0.0173	CbGeAlD
Nifedipine—CYP3A5—islet of Langerhans—pancreatic cancer	0.000585	0.0156	CbGeAlD
Nifedipine—CALM2—pancreas—pancreatic cancer	0.000549	0.0146	CbGeAlD
Nifedipine—CALM1—pancreas—pancreatic cancer	0.000547	0.0146	CbGeAlD
Nifedipine—ABCC2—digestive system—pancreatic cancer	0.000518	0.0138	CbGeAlD
Nifedipine—CALM2—digestive system—pancreatic cancer	0.000469	0.0125	CbGeAlD
Nifedipine—CALM1—digestive system—pancreatic cancer	0.000467	0.0124	CbGeAlD
Nifedipine—CYP3A5—pancreas—pancreatic cancer	0.000411	0.0109	CbGeAlD
Nifedipine—CYP1A2—digestive system—pancreatic cancer	0.000364	0.00969	CbGeAlD
Nifedipine—CYP1A1—digestive system—pancreatic cancer	0.000359	0.00956	CbGeAlD
Nifedipine—CYP3A5—digestive system—pancreatic cancer	0.000351	0.00935	CbGeAlD
Nifedipine—CYP2B6—digestive system—pancreatic cancer	0.000349	0.00929	CbGeAlD
Nifedipine—CYP2C9—digestive system—pancreatic cancer	0.000345	0.0092	CbGeAlD
Nifedipine—CYP2E1—digestive system—pancreatic cancer	0.000327	0.00872	CbGeAlD
Nifedipine—ABCB1—islet of Langerhans—pancreatic cancer	0.000311	0.00827	CbGeAlD
Nifedipine—CYP3A4—digestive system—pancreatic cancer	0.000263	0.00702	CbGeAlD
Nifedipine—CYP2D6—digestive system—pancreatic cancer	0.000259	0.0069	CbGeAlD
Nifedipine—ABCB1—pancreas—pancreatic cancer	0.000218	0.00582	CbGeAlD
Nifedipine—ABCB1—digestive system—pancreatic cancer	0.000186	0.00497	CbGeAlD
Nifedipine—Asthenia—Gemcitabine—pancreatic cancer	9.25e-05	0.000505	CcSEcCtD
Nifedipine—Haematuria—Epirubicin—pancreatic cancer	9.23e-05	0.000504	CcSEcCtD
Nifedipine—Confusional state—Docetaxel—pancreatic cancer	9.22e-05	0.000504	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	9.16e-05	0.000501	CcSEcCtD
Nifedipine—Hepatobiliary disease—Epirubicin—pancreatic cancer	9.15e-05	0.0005	CcSEcCtD
Nifedipine—Anaphylactic shock—Docetaxel—pancreatic cancer	9.15e-05	0.0005	CcSEcCtD
Nifedipine—Oedema—Docetaxel—pancreatic cancer	9.15e-05	0.0005	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—pancreatic cancer	9.14e-05	0.000499	CcSEcCtD
Nifedipine—Epistaxis—Epirubicin—pancreatic cancer	9.13e-05	0.000499	CcSEcCtD
Nifedipine—Pruritus—Gemcitabine—pancreatic cancer	9.12e-05	0.000498	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—pancreatic cancer	9.08e-05	0.000496	CcSEcCtD
Nifedipine—Sinusitis—Epirubicin—pancreatic cancer	9.08e-05	0.000496	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.06e-05	0.000495	CcSEcCtD
Nifedipine—Diarrhoea—Irinotecan—pancreatic cancer	9.06e-05	0.000495	CcSEcCtD
Nifedipine—Agranulocytosis—Epirubicin—pancreatic cancer	9.03e-05	0.000493	CcSEcCtD
Nifedipine—Shock—Docetaxel—pancreatic cancer	9e-05	0.000492	CcSEcCtD
Nifedipine—Nervous system disorder—Docetaxel—pancreatic cancer	8.97e-05	0.00049	CcSEcCtD
Nifedipine—Pruritus—Fluorouracil—pancreatic cancer	8.97e-05	0.00049	CcSEcCtD
Nifedipine—Thrombocytopenia—Docetaxel—pancreatic cancer	8.96e-05	0.000489	CcSEcCtD
Nifedipine—Tachycardia—Docetaxel—pancreatic cancer	8.93e-05	0.000488	CcSEcCtD
Nifedipine—Skin disorder—Docetaxel—pancreatic cancer	8.89e-05	0.000486	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.88e-05	0.000485	CcSEcCtD
Nifedipine—Bradycardia—Epirubicin—pancreatic cancer	8.84e-05	0.000483	CcSEcCtD
Nifedipine—Diarrhoea—Gemcitabine—pancreatic cancer	8.82e-05	0.000482	CcSEcCtD
Nifedipine—Dizziness—Irinotecan—pancreatic cancer	8.75e-05	0.000478	CcSEcCtD
Nifedipine—Haemoglobin—Epirubicin—pancreatic cancer	8.73e-05	0.000477	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—pancreatic cancer	8.73e-05	0.000477	CcSEcCtD
Nifedipine—Anorexia—Docetaxel—pancreatic cancer	8.72e-05	0.000477	CcSEcCtD
Nifedipine—Rhinitis—Epirubicin—pancreatic cancer	8.71e-05	0.000476	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—pancreatic cancer	8.7e-05	0.000475	CcSEcCtD
Nifedipine—Haemorrhage—Epirubicin—pancreatic cancer	8.69e-05	0.000475	CcSEcCtD
Nifedipine—Hepatitis—Epirubicin—pancreatic cancer	8.69e-05	0.000475	CcSEcCtD
Nifedipine—Diarrhoea—Fluorouracil—pancreatic cancer	8.67e-05	0.000474	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—pancreatic cancer	8.64e-05	0.000472	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—pancreatic cancer	8.62e-05	0.000471	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—pancreatic cancer	8.58e-05	0.000469	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—pancreatic cancer	8.58e-05	0.000469	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—pancreatic cancer	8.56e-05	0.000468	CcSEcCtD
Nifedipine—Hypotension—Docetaxel—pancreatic cancer	8.55e-05	0.000467	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—pancreatic cancer	8.54e-05	0.000466	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—pancreatic cancer	8.54e-05	0.000466	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—pancreatic cancer	8.51e-05	0.000465	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	8.47e-05	0.000463	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—pancreatic cancer	8.44e-05	0.000461	CcSEcCtD
Nifedipine—Vomiting—Irinotecan—pancreatic cancer	8.41e-05	0.00046	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—pancreatic cancer	8.4e-05	0.000459	CcSEcCtD
Nifedipine—Dizziness—Fluorouracil—pancreatic cancer	8.38e-05	0.000458	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—pancreatic cancer	8.37e-05	0.000457	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—pancreatic cancer	8.35e-05	0.000457	CcSEcCtD
Nifedipine—Rash—Irinotecan—pancreatic cancer	8.34e-05	0.000456	CcSEcCtD
Nifedipine—Dermatitis—Irinotecan—pancreatic cancer	8.34e-05	0.000456	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.34e-05	0.000455	CcSEcCtD
Nifedipine—Headache—Irinotecan—pancreatic cancer	8.29e-05	0.000453	CcSEcCtD
Nifedipine—Insomnia—Docetaxel—pancreatic cancer	8.27e-05	0.000452	CcSEcCtD
Nifedipine—Paraesthesia—Docetaxel—pancreatic cancer	8.22e-05	0.000449	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—pancreatic cancer	8.21e-05	0.000449	CcSEcCtD
Nifedipine—Vomiting—Gemcitabine—pancreatic cancer	8.2e-05	0.000448	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—pancreatic cancer	8.18e-05	0.000447	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—pancreatic cancer	8.16e-05	0.000446	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—pancreatic cancer	8.13e-05	0.000444	CcSEcCtD
Nifedipine—Rash—Gemcitabine—pancreatic cancer	8.13e-05	0.000444	CcSEcCtD
Nifedipine—Dermatitis—Gemcitabine—pancreatic cancer	8.12e-05	0.000444	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—pancreatic cancer	8.12e-05	0.000444	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—pancreatic cancer	8.1e-05	0.000443	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—pancreatic cancer	8.08e-05	0.000441	CcSEcCtD
Nifedipine—Headache—Gemcitabine—pancreatic cancer	8.08e-05	0.000441	CcSEcCtD
Nifedipine—Flushing—Epirubicin—pancreatic cancer	8.06e-05	0.00044	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—pancreatic cancer	8.06e-05	0.00044	CcSEcCtD
Nifedipine—Vomiting—Fluorouracil—pancreatic cancer	8.06e-05	0.00044	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—pancreatic cancer	8.06e-05	0.00044	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—pancreatic cancer	8.05e-05	0.00044	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—pancreatic cancer	8.04e-05	0.000439	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—pancreatic cancer	8.04e-05	0.000439	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—pancreatic cancer	8e-05	0.000437	CcSEcCtD
Nifedipine—Rash—Fluorouracil—pancreatic cancer	7.99e-05	0.000437	CcSEcCtD
Nifedipine—Dermatitis—Fluorouracil—pancreatic cancer	7.98e-05	0.000436	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—pancreatic cancer	7.98e-05	0.000436	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—pancreatic cancer	7.95e-05	0.000435	CcSEcCtD
Nifedipine—Headache—Fluorouracil—pancreatic cancer	7.94e-05	0.000434	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.94e-05	0.000434	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—pancreatic cancer	7.92e-05	0.000433	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.9e-05	0.000432	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.9e-05	0.000432	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—pancreatic cancer	7.89e-05	0.000431	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—pancreatic cancer	7.88e-05	0.000431	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—pancreatic cancer	7.88e-05	0.00043	CcSEcCtD
Nifedipine—Nausea—Irinotecan—pancreatic cancer	7.86e-05	0.00043	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—pancreatic cancer	7.85e-05	0.000429	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—pancreatic cancer	7.83e-05	0.000428	CcSEcCtD
Nifedipine—Constipation—Docetaxel—pancreatic cancer	7.82e-05	0.000427	CcSEcCtD
Nifedipine—Pain—Docetaxel—pancreatic cancer	7.82e-05	0.000427	CcSEcCtD
Nifedipine—Chills—Epirubicin—pancreatic cancer	7.79e-05	0.000426	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—pancreatic cancer	7.76e-05	0.000424	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—pancreatic cancer	7.74e-05	0.000423	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—pancreatic cancer	7.68e-05	0.000419	CcSEcCtD
Nifedipine—Nausea—Gemcitabine—pancreatic cancer	7.66e-05	0.000418	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—pancreatic cancer	7.61e-05	0.000416	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—pancreatic cancer	7.6e-05	0.000415	CcSEcCtD
Nifedipine—Erythema—Epirubicin—pancreatic cancer	7.56e-05	0.000413	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—pancreatic cancer	7.56e-05	0.000413	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—pancreatic cancer	7.54e-05	0.000412	CcSEcCtD
Nifedipine—Nausea—Fluorouracil—pancreatic cancer	7.53e-05	0.000411	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—pancreatic cancer	7.51e-05	0.00041	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—pancreatic cancer	7.49e-05	0.000409	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.48e-05	0.000409	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—pancreatic cancer	7.46e-05	0.000408	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—pancreatic cancer	7.46e-05	0.000408	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—pancreatic cancer	7.45e-05	0.000407	CcSEcCtD
Nifedipine—Tension—Epirubicin—pancreatic cancer	7.42e-05	0.000405	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—pancreatic cancer	7.4e-05	0.000405	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—pancreatic cancer	7.34e-05	0.000401	CcSEcCtD
Nifedipine—Back pain—Epirubicin—pancreatic cancer	7.31e-05	0.0004	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—pancreatic cancer	7.29e-05	0.000398	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—pancreatic cancer	7.27e-05	0.000397	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—pancreatic cancer	7.26e-05	0.000397	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.24e-05	0.000396	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—pancreatic cancer	7.23e-05	0.000395	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—pancreatic cancer	7.23e-05	0.000395	CcSEcCtD
Nifedipine—Chills—Doxorubicin—pancreatic cancer	7.21e-05	0.000394	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—pancreatic cancer	7.18e-05	0.000392	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—pancreatic cancer	7.13e-05	0.000389	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—pancreatic cancer	7.1e-05	0.000388	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—pancreatic cancer	7.04e-05	0.000385	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—pancreatic cancer	7.02e-05	0.000383	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—pancreatic cancer	7e-05	0.000382	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—pancreatic cancer	7e-05	0.000382	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—pancreatic cancer	6.99e-05	0.000382	CcSEcCtD
Nifedipine—Agitation—Epirubicin—pancreatic cancer	6.95e-05	0.00038	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—pancreatic cancer	6.89e-05	0.000377	CcSEcCtD
Nifedipine—Tension—Doxorubicin—pancreatic cancer	6.87e-05	0.000375	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—pancreatic cancer	6.85e-05	0.000374	CcSEcCtD
Nifedipine—Malaise—Epirubicin—pancreatic cancer	6.82e-05	0.000373	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—pancreatic cancer	6.79e-05	0.000371	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—pancreatic cancer	6.79e-05	0.000371	CcSEcCtD
Nifedipine—Syncope—Epirubicin—pancreatic cancer	6.78e-05	0.00037	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—pancreatic cancer	6.77e-05	0.00037	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—pancreatic cancer	6.77e-05	0.00037	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—pancreatic cancer	6.74e-05	0.000368	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—pancreatic cancer	6.73e-05	0.000368	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—pancreatic cancer	6.68e-05	0.000365	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—pancreatic cancer	6.65e-05	0.000363	CcSEcCtD
Nifedipine—Cough—Epirubicin—pancreatic cancer	6.6e-05	0.000361	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—pancreatic cancer	6.59e-05	0.00036	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—pancreatic cancer	6.56e-05	0.000359	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.49e-05	0.000355	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—pancreatic cancer	6.47e-05	0.000354	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—pancreatic cancer	6.47e-05	0.000353	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—pancreatic cancer	6.44e-05	0.000352	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—pancreatic cancer	6.44e-05	0.000352	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—pancreatic cancer	6.44e-05	0.000352	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—pancreatic cancer	6.43e-05	0.000351	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—pancreatic cancer	6.41e-05	0.000351	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.39e-05	0.000349	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—pancreatic cancer	6.36e-05	0.000348	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—pancreatic cancer	6.31e-05	0.000345	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—pancreatic cancer	6.3e-05	0.000344	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—pancreatic cancer	6.29e-05	0.000343	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—pancreatic cancer	6.27e-05	0.000343	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—pancreatic cancer	6.26e-05	0.000342	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—pancreatic cancer	6.26e-05	0.000342	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—pancreatic cancer	6.22e-05	0.00034	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—pancreatic cancer	6.18e-05	0.000338	CcSEcCtD
Nifedipine—Oedema—Epirubicin—pancreatic cancer	6.17e-05	0.000337	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—pancreatic cancer	6.17e-05	0.000337	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—pancreatic cancer	6.15e-05	0.000336	CcSEcCtD
Nifedipine—Cough—Doxorubicin—pancreatic cancer	6.1e-05	0.000334	CcSEcCtD
Nifedipine—Shock—Epirubicin—pancreatic cancer	6.07e-05	0.000332	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—pancreatic cancer	6.05e-05	0.000331	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—pancreatic cancer	6.05e-05	0.000331	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—pancreatic cancer	6.04e-05	0.00033	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—pancreatic cancer	6.02e-05	0.000329	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—pancreatic cancer	5.99e-05	0.000328	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—pancreatic cancer	5.97e-05	0.000326	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—pancreatic cancer	5.96e-05	0.000325	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—pancreatic cancer	5.96e-05	0.000325	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—pancreatic cancer	5.96e-05	0.000325	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—pancreatic cancer	5.94e-05	0.000324	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.92e-05	0.000323	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—pancreatic cancer	5.88e-05	0.000322	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—pancreatic cancer	5.88e-05	0.000321	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—pancreatic cancer	5.83e-05	0.000318	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—pancreatic cancer	5.82e-05	0.000318	CcSEcCtD
Nifedipine—Rash—Docetaxel—pancreatic cancer	5.77e-05	0.000315	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—pancreatic cancer	5.77e-05	0.000315	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—pancreatic cancer	5.76e-05	0.000315	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—pancreatic cancer	5.76e-05	0.000315	CcSEcCtD
Nifedipine—Headache—Docetaxel—pancreatic cancer	5.73e-05	0.000313	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—pancreatic cancer	5.71e-05	0.000312	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.71e-05	0.000312	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.62e-05	0.000307	CcSEcCtD
Nifedipine—Shock—Doxorubicin—pancreatic cancer	5.62e-05	0.000307	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—pancreatic cancer	5.6e-05	0.000306	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.59e-05	0.000305	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—pancreatic cancer	5.58e-05	0.000305	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—pancreatic cancer	5.57e-05	0.000304	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—pancreatic cancer	5.55e-05	0.000303	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—pancreatic cancer	5.54e-05	0.000303	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.52e-05	0.000302	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—pancreatic cancer	5.5e-05	0.000301	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—pancreatic cancer	5.49e-05	0.0003	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—pancreatic cancer	5.44e-05	0.000297	CcSEcCtD
Nifedipine—Nausea—Docetaxel—pancreatic cancer	5.43e-05	0.000297	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—pancreatic cancer	5.43e-05	0.000297	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—pancreatic cancer	5.36e-05	0.000293	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—pancreatic cancer	5.34e-05	0.000292	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.33e-05	0.000291	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—pancreatic cancer	5.32e-05	0.000291	CcSEcCtD
Nifedipine—Constipation—Epirubicin—pancreatic cancer	5.28e-05	0.000288	CcSEcCtD
Nifedipine—Pain—Epirubicin—pancreatic cancer	5.28e-05	0.000288	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.2e-05	0.000284	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—pancreatic cancer	5.16e-05	0.000282	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—pancreatic cancer	5.13e-05	0.00028	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—pancreatic cancer	5.09e-05	0.000278	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—pancreatic cancer	5.09e-05	0.000278	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—pancreatic cancer	5.08e-05	0.000277	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.05e-05	0.000276	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—pancreatic cancer	5.03e-05	0.000275	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—pancreatic cancer	4.96e-05	0.000271	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.93e-05	0.000269	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—pancreatic cancer	4.92e-05	0.000269	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—pancreatic cancer	4.9e-05	0.000268	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—pancreatic cancer	4.88e-05	0.000267	CcSEcCtD
Nifedipine—Pain—Doxorubicin—pancreatic cancer	4.88e-05	0.000267	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—pancreatic cancer	4.88e-05	0.000267	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—pancreatic cancer	4.88e-05	0.000267	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.71e-05	0.000257	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.67e-05	0.000255	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—pancreatic cancer	4.55e-05	0.000248	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—pancreatic cancer	4.54e-05	0.000248	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—pancreatic cancer	4.51e-05	0.000247	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—pancreatic cancer	4.51e-05	0.000247	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—pancreatic cancer	4.43e-05	0.000242	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—pancreatic cancer	4.37e-05	0.000239	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—pancreatic cancer	4.22e-05	0.000231	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—pancreatic cancer	4.21e-05	0.00023	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—pancreatic cancer	4.1e-05	0.000224	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—pancreatic cancer	4.08e-05	0.000223	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—pancreatic cancer	4.04e-05	0.000221	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—pancreatic cancer	3.92e-05	0.000214	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—pancreatic cancer	3.91e-05	0.000213	CcSEcCtD
Nifedipine—Rash—Epirubicin—pancreatic cancer	3.89e-05	0.000213	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—pancreatic cancer	3.89e-05	0.000212	CcSEcCtD
Nifedipine—Headache—Epirubicin—pancreatic cancer	3.87e-05	0.000211	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—pancreatic cancer	3.78e-05	0.000206	CcSEcCtD
Nifedipine—Nausea—Epirubicin—pancreatic cancer	3.67e-05	0.0002	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—pancreatic cancer	3.63e-05	0.000198	CcSEcCtD
Nifedipine—Rash—Doxorubicin—pancreatic cancer	3.6e-05	0.000197	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—pancreatic cancer	3.6e-05	0.000197	CcSEcCtD
Nifedipine—Headache—Doxorubicin—pancreatic cancer	3.58e-05	0.000195	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—pancreatic cancer	3.39e-05	0.000185	CcSEcCtD
Nifedipine—CALM1—Signaling Pathways—NFKBIA—pancreatic cancer	4.08e-06	5.12e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.08e-06	5.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PTEN—pancreatic cancer	4.05e-06	5.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PTEN—pancreatic cancer	4.05e-06	5.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOTCH1—pancreatic cancer	4.04e-06	5.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOTCH1—pancreatic cancer	4.04e-06	5.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGF—pancreatic cancer	4.04e-06	5.07e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.03e-06	5.06e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CD44—pancreatic cancer	4.01e-06	5.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—pancreatic cancer	4.01e-06	5.03e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—pancreatic cancer	4.01e-06	5.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—pancreatic cancer	3.98e-06	4.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CTNNB1—pancreatic cancer	3.97e-06	4.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CG—pancreatic cancer	3.95e-06	4.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CG—pancreatic cancer	3.95e-06	4.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—NRAS—pancreatic cancer	3.95e-06	4.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—NRAS—pancreatic cancer	3.95e-06	4.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGF—pancreatic cancer	3.91e-06	4.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGF—pancreatic cancer	3.91e-06	4.9e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—SRC—pancreatic cancer	3.88e-06	4.87e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOE—pancreatic cancer	3.87e-06	4.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTEN—pancreatic cancer	3.86e-06	4.85e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	3.85e-06	4.83e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—pancreatic cancer	3.85e-06	4.83e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—pancreatic cancer	3.85e-06	4.83e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GCG—pancreatic cancer	3.85e-06	4.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—pancreatic cancer	3.84e-06	4.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—pancreatic cancer	3.84e-06	4.81e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOE—pancreatic cancer	3.83e-06	4.81e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	3.81e-06	4.78e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—pancreatic cancer	3.79e-06	4.76e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	3.77e-06	4.73e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.76e-06	4.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—SRC—pancreatic cancer	3.76e-06	4.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—SRC—pancreatic cancer	3.76e-06	4.71e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CB—pancreatic cancer	3.75e-06	4.7e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—STAT3—pancreatic cancer	3.74e-06	4.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTEN—pancreatic cancer	3.74e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTEN—pancreatic cancer	3.74e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.74e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	3.74e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NRAS—pancreatic cancer	3.73e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.73e-06	4.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—pancreatic cancer	3.72e-06	4.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—pancreatic cancer	3.71e-06	4.66e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.7e-06	4.65e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.63e-06	4.55e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CB—pancreatic cancer	3.62e-06	4.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CB—pancreatic cancer	3.62e-06	4.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—STAT3—pancreatic cancer	3.62e-06	4.54e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—STAT3—pancreatic cancer	3.62e-06	4.54e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—STK11—pancreatic cancer	3.62e-06	4.54e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—pancreatic cancer	3.61e-06	4.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—pancreatic cancer	3.61e-06	4.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—pancreatic cancer	3.6e-06	4.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—pancreatic cancer	3.6e-06	4.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CD—pancreatic cancer	3.59e-06	4.51e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—pancreatic cancer	3.59e-06	4.5e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—pancreatic cancer	3.59e-06	4.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—SRC—pancreatic cancer	3.58e-06	4.5e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—pancreatic cancer	3.58e-06	4.49e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.55e-06	4.46e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.52e-06	4.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—pancreatic cancer	3.52e-06	4.41e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.49e-06	4.38e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—pancreatic cancer	3.48e-06	4.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—pancreatic cancer	3.48e-06	4.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—pancreatic cancer	3.47e-06	4.35e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—pancreatic cancer	3.47e-06	4.35e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.46e-06	4.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—pancreatic cancer	3.46e-06	4.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—pancreatic cancer	3.45e-06	4.33e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—pancreatic cancer	3.4e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—pancreatic cancer	3.4e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—pancreatic cancer	3.4e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.37e-06	4.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—pancreatic cancer	3.34e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—pancreatic cancer	3.34e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.34e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—pancreatic cancer	3.34e-06	4.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—pancreatic cancer	3.34e-06	4.18e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.33e-06	4.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—pancreatic cancer	3.29e-06	4.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—pancreatic cancer	3.29e-06	4.13e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOE—pancreatic cancer	3.28e-06	4.11e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.26e-06	4.09e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.26e-06	4.09e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.26e-06	4.09e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.25e-06	4.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—pancreatic cancer	3.24e-06	4.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	3.23e-06	4.06e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.23e-06	4.05e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—pancreatic cancer	3.21e-06	4.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—pancreatic cancer	3.21e-06	4.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—pancreatic cancer	3.2e-06	4.02e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	3.17e-06	3.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—pancreatic cancer	3.14e-06	3.94e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	3.13e-06	3.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—pancreatic cancer	3.13e-06	3.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—pancreatic cancer	3.13e-06	3.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.13e-06	3.92e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.13e-06	3.92e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.11e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—pancreatic cancer	3.11e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—pancreatic cancer	3.11e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—pancreatic cancer	3.11e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—pancreatic cancer	3.11e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.1e-06	3.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—pancreatic cancer	3.1e-06	3.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—pancreatic cancer	3.1e-06	3.89e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.07e-06	3.85e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.07e-06	3.85e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	3.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—pancreatic cancer	3.04e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—pancreatic cancer	3.04e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.03e-06	3.8e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.03e-06	3.8e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	3.01e-06	3.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	2.99e-06	3.75e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—pancreatic cancer	2.97e-06	3.72e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.96e-06	3.71e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—pancreatic cancer	2.95e-06	3.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	2.91e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	2.91e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.91e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	2.89e-06	3.63e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	2.89e-06	3.63e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	2.88e-06	3.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—pancreatic cancer	2.87e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—pancreatic cancer	2.87e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—pancreatic cancer	2.86e-06	3.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—pancreatic cancer	2.86e-06	3.58e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.85e-06	3.58e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.84e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.82e-06	3.53e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.81e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	2.8e-06	3.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	2.79e-06	3.5e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	2.79e-06	3.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.78e-06	3.48e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—pancreatic cancer	2.73e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—pancreatic cancer	2.73e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	2.72e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	2.71e-06	3.4e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	2.71e-06	3.4e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	2.71e-06	3.4e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.69e-06	3.37e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.69e-06	3.37e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.68e-06	3.36e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	3.33e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.65e-06	3.33e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—pancreatic cancer	2.64e-06	3.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—pancreatic cancer	2.64e-06	3.32e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—pancreatic cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—pancreatic cancer	2.64e-06	3.31e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	2.63e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	2.63e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.63e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	2.62e-06	3.28e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	2.62e-06	3.28e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.6e-06	3.26e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.59e-06	3.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	2.55e-06	3.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	2.55e-06	3.2e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOE—pancreatic cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—pancreatic cancer	2.52e-06	3.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—pancreatic cancer	2.51e-06	3.15e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.45e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	2.44e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—pancreatic cancer	2.44e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—pancreatic cancer	2.44e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—pancreatic cancer	2.43e-06	3.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—pancreatic cancer	2.43e-06	3.05e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	2.42e-06	3.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	2.41e-06	3.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—pancreatic cancer	2.41e-06	3.03e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.38e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	2.36e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	2.36e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.35e-06	2.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	2.34e-06	2.94e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	2.34e-06	2.94e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	2.34e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	2.34e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—pancreatic cancer	2.33e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—pancreatic cancer	2.33e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.31e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.3e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.29e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—pancreatic cancer	2.28e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.28e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.27e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—pancreatic cancer	2.25e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.25e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	2.24e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—pancreatic cancer	2.23e-06	2.79e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.2e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	2.2e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—pancreatic cancer	2.18e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—pancreatic cancer	2.18e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	2.17e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	2.17e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.17e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—pancreatic cancer	2.15e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—pancreatic cancer	2.15e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	2.13e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	2.13e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	2.08e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	2.01e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	2.01e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.01e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.96e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.92e-06	2.4e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.91e-06	2.4e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.88e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.87e-06	2.35e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—pancreatic cancer	1.87e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—pancreatic cancer	1.85e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.85e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.85e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—pancreatic cancer	1.8e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—pancreatic cancer	1.8e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—pancreatic cancer	1.79e-06	2.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—pancreatic cancer	1.79e-06	2.24e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.77e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	1.77e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.75e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.73e-06	2.17e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	1.71e-06	2.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	1.71e-06	2.14e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	2.05e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.62e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	1.56e-06	1.96e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	1.51e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	1.51e-06	1.89e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.41e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.38e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.33e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.32e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.13e-06	1.42e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.71e-07	1.09e-05	CbGpPWpGaD
